TENAX THERAPEUTICS, INC. Diluted Shares Outstanding (Weighted Average)
TENAX THERAPEUTICS, INC. (TENX) reported Diluted Shares Outstanding (Weighted Average) of 50.87 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-07-31
- TENAX THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 50.87M shares, a 28.55% increase year-over-year.
- TENAX THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 45.23M shares, a 23.62% increase year-over-year.
- TENAX THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 40.94M shares, a 12.96% increase year-over-year.
- TENAX THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 39.74M shares, a 87.80% increase year-over-year.
- TENAX THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 39.22M shares, a 156.80% increase from fiscal 2024.
- TENAX THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 15.27M shares, a 6046.87% increase from fiscal 2023.
- TENAX THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 248.45K shares.
- TENAX THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2015 was 28.08M shares, a 199.91% increase from fiscal 2014.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 8 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 50.87M shares 10-Q · filed 2026-07-31 | 48.06M shares 10-Q · filed 2026-07-31 | 45.68M shares derived: average of 3 quarters · filed 2026-07-31 | 44.19M shares derived: average of 4 quarters · filed 2026-07-31 | |||||
| 2026-03-31 | 45.23M shares 10-Q · filed 2026-05-12 | 43.08M shares derived: average of 2 quarters · filed 2026-05-12 | 41.97M shares derived: average of 3 quarters · filed 2026-05-12 | 41.37M shares derived: average of 4 quarters · filed 2026-07-31 | |||||
| 2025-12-31 | 40.94M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 40.34M shares derived: average of 2 quarters · filed 2026-03-10 | 40.08M shares derived: average of 3 quarters · filed 2026-07-31 | 39.22M shares 10-K · filed 2026-03-10 | |||||
| 2025-09-30 | 39.74M shares 10-Q · filed 2025-11-12 | 39.66M shares derived: average of 2 quarters · filed 2026-07-31 | 38.64M shares 10-Q · filed 2025-11-12 | 38.03M shares derived: average of 4 quarters · filed 2026-07-31 | |||||
| 2025-06-30 | 39.57M shares 10-Q · filed 2026-07-31 | 38.09M shares 10-Q · filed 2026-07-31 | 37.47M shares derived: average of 3 quarters · filed 2026-07-31 | 33.39M shares derived: average of 4 quarters · filed 2026-07-31 | |||||
| 2025-03-31 | 36.58M shares 10-Q · filed 2026-05-12 | 36.41M shares derived: average of 2 quarters · filed 2026-05-12 | 31.33M shares derived: average of 3 quarters · filed 2026-05-12 | 23.99M shares derived: average of 4 quarters · filed 2026-05-12 | |||||
| 2024-12-31 | 36.24M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 28.70M shares derived: average of 2 quarters · filed 2026-03-10 | 19.79M shares derived: average of 3 quarters · filed 2026-03-10 | 15.27M shares 10-K · filed 2026-03-10 | |||||
| 2024-09-30 | 21.16M shares 10-Q · filed 2025-11-12 | 11.56M shares derived: average of 2 quarters · filed 2025-11-12 | 8.28M shares 10-Q · filed 2025-11-12 | ||||||
| 2024-06-30 | 1.96M shares 10-Q · filed 2025-08-13 | 1.59M shares 10-Q · filed 2025-08-13 | |||||||
| 2024-03-31 | 1.22M shares 10-Q · filed 2025-05-14 | ||||||||
| 2023-12-31 | 248.45K shares 10-K · filed 2025-03-25 | ||||||||
| 2015-12-31 | 28.12M shares 10-KT · filed 2016-03-14 | ||||||||
| 2015-04-30 | 28.12M shares derived: 10-KT 12 month − 10-Q 9 month · filed 2016-03-14 | 28.12M shares derived: average of 2 quarters · filed 2016-03-14 | 28.11M shares derived: average of 3 quarters · filed 2016-03-14 | 28.08M shares 10-KT · filed 2016-03-14 | |||||
| 2015-01-31 | 28.12M shares 10-Q · filed 2015-03-17 | 28.11M shares derived: average of 2 quarters · filed 2015-03-17 | 28.06M shares 10-Q · filed 2015-03-17 | 25.97M shares derived: average of 4 quarters · filed 2016-03-14 | |||||
| 2014-10-31 | 28.11M shares 10-Q · filed 2014-12-15 | 28.04M shares 10-Q · filed 2014-12-15 | 25.25M shares derived: average of 3 quarters · filed 2016-03-14 | 21.51M shares derived: average of 4 quarters · filed 2016-03-14 | |||||
| 2014-07-31 | 27.66M shares 10-Q · filed 2014-09-15 | 23.83M shares derived: average of 2 quarters · filed 2016-03-14 | 19.31M shares derived: average of 3 quarters · filed 2016-03-14 | 15.72M shares derived: average of 4 quarters · filed 2016-03-14 | |||||
| 2014-04-30 | 19.99M shares derived: 10-KT 12 month − 10-Q 9 month · filed 2016-03-14 | 15.13M shares derived: average of 2 quarters · filed 2016-03-14 | 11.74M shares derived: average of 3 quarters · filed 2016-03-14 | 9.36M shares 10-KT · filed 2016-03-14 | |||||
| 2014-01-31 | 10.27M shares 10-Q · filed 2015-03-17 | 7.61M shares derived: average of 2 quarters · filed 2015-03-17 | 5.82M shares 10-Q · filed 2015-03-17 | 4.84M shares derived: average of 4 quarters · filed 2016-03-14 | |||||
| 2013-10-31 | 4.95M shares 10-Q · filed 2014-12-15 | 3.56M shares 10-Q · filed 2014-12-15 | 3.03M shares derived: average of 3 quarters · filed 2016-03-14 | 2.72M shares derived: average of 4 quarters · filed 2016-03-14 | |||||
| 2013-07-31 | 2.21M shares 10-Q · filed 2014-09-15 | 2.07M shares derived: average of 2 quarters · filed 2016-03-14 | 1.97M shares derived: average of 3 quarters · filed 2016-03-14 | 1.91M shares derived: average of 4 quarters · filed 2016-03-14 | |||||
| 2013-04-30 | 1.94M shares derived: 10-KT 12 month − 10-Q 9 month · filed 2016-03-14 | 1.85M shares derived: average of 2 quarters · filed 2016-03-14 | 1.81M shares derived: average of 3 quarters · filed 2016-03-14 | 1.76M shares 10-KT · filed 2016-03-14 | |||||
| 2013-01-31 | 1.77M shares 10-Q · filed 2014-03-17 | 35.35M shares 10-Q · filed 2013-03-18 | 1.74M shares derived: average of 2 quarters · filed 2014-03-17 | 1.70M shares 10-Q · filed 2014-03-17 | 34.00M shares 10-Q · filed 2013-03-18 | -17.31M shares derived: average of 4 quarters · filed 2014-03-17 | |||
| 2012-10-31 | 1.71M shares 10-Q · filed 2013-12-17 | 34.25M shares 10-Q · filed 2012-12-14 | 1.67M shares 10-Q · filed 2013-12-17 | 33.34M shares 10-Q · filed 2012-12-14 | -23.67M shares derived: average of 3 quarters · filed 2013-12-17 | -10.32M shares derived: average of 4 quarters · filed 2013-12-17 | |||
| 2012-07-31 | 1.62M shares 10-Q · filed 2013-09-17 | 32.36M shares 10-Q · filed 2012-09-19 | -36.36M shares derived: average of 2 quarters · filed 2013-09-17 | -14.33M shares derived: average of 3 quarters · filed 2013-09-17 | -4.25M shares derived: average of 4 quarters · filed 2013-09-17 | ||||
| 2012-04-30 | -74.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-26 | -22.30M shares derived: average of 2 quarters · filed 2013-06-26 | -6.21M shares derived: average of 3 quarters · filed 2013-06-26 | 1.39M shares 10-K · filed 2013-06-26 | 27.75M shares 10-K · filed 2012-07-25 | ||||
| 2012-01-31 | 29.73M shares 10-Q · filed 2013-03-18 | 27.86M shares derived: average of 2 quarters · filed 2013-03-18 | 26.63M shares 10-Q · filed 2013-03-18 | 25.81M shares derived: average of 4 quarters · filed 2013-03-18 | |||||
| 2011-10-31 | 25.98M shares 10-Q · filed 2012-12-14 | 25.08M shares 10-Q · filed 2012-12-14 | 24.51M shares derived: average of 3 quarters · filed 2012-12-14 | 24.23M shares derived: average of 4 quarters · filed 2012-12-14 | |||||
| 2011-07-31 | 24.14M shares 10-Q · filed 2012-09-19 | 23.77M shares derived: average of 2 quarters · filed 2012-09-19 | 23.64M shares derived: average of 3 quarters · filed 2012-09-19 | 23.58M shares derived: average of 4 quarters · filed 2012-09-19 | |||||
| 2011-04-30 | 23.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-25 | 23.39M shares derived: average of 2 quarters · filed 2012-07-25 | 23.39M shares derived: average of 3 quarters · filed 2012-07-25 | 23.35M shares 10-K · filed 2012-07-25 | |||||
| 2011-01-31 | 23.39M shares 10-Q · filed 2012-03-15 | 23.39M shares derived: average of 2 quarters · filed 2012-03-15 | 23.33M shares 10-Q · filed 2012-03-15 | ||||||
| 2010-10-31 | 23.39M shares 10-Q · filed 2011-12-15 | 23.30M shares 10-Q · filed 2011-12-15 | |||||||
| 2010-07-31 | 23.22M shares 10-Q · filed 2011-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |